Iteos Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of December 2024: 2.50x

Iteos Therapeutics Inc cash flow reinvestment rate. Iteos Therapeutics Inc (ITOS) has a Cash Flow Reinvestment Rate of 2.50x as of December 2024, reinvesting $13.77 Million (capex $152.00K plus investments $13.62 Million) from operating cash flow of $5.50 Million. Explore ITOS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

2.50x

(Capex + Investments) / Operating CF

Total Reinvested

$13.77 Million

Capex + Investments

Operating Cash Flow

$5.50 Million

USD

Capital Expenditures

$152.00K

USD

Cash Flow Reinvestment Rate of Iteos Therapeutics Inc (2021–2021)

Cash flow reinvestment rate of Iteos Therapeutics Inc from 2021 to 2021. Historical reinvestment intensity for Iteos Therapeutics Inc across 1 annual periods. Explore ITOS capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Iteos Therapeutics Inc Cash Flow Reinvestment Rate by Year (2021–2021)

Iteos Therapeutics Inc cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for Iteos Therapeutics Inc. For the full cash flow conversion analysis, see Iteos Therapeutics Inc (ITOS) cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2021	0.00x	$2.42 Million	$513.14 Million	$1.18 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow